A round of funding led by Norwest Venture Partners and Janus Capital Management funds has brought in $47 million for Sunnyvale, Calif.-based Silk Road Medical. The proceeds will be used to support commercial growth of the company's ENROUTE products for transcarotid artery revascularization procedures.
Funding round pulls in $47M for Silk Road Medical
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.